BCAL Diagnostics (ASX:BDX) Total Liabilities : A$2.36 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Total Liabilities?

BCAL Diagnostics's Total Liabilities for the quarter that ended in Dec. 2023 was A$2.36 Mil.

BCAL Diagnostics's quarterly Total Liabilities increased from Dec. 2022 (A$0.41 Mil) to Jun. 2023 (A$3.16 Mil) but then declined from Jun. 2023 (A$3.16 Mil) to Dec. 2023 (A$2.36 Mil).

BCAL Diagnostics's annual Total Liabilities increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$0.95 Mil) and increased from Jun. 2022 (A$0.95 Mil) to Jun. 2023 (A$3.16 Mil).

BCAL Diagnostics Total Liabilities Historical Data

The historical data trend for BCAL Diagnostics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Total Liabilities Chart

BCAL Diagnostics Annual Data

Trend

Jun22

Jun23

Total Liabilities

0.95

3.16

BCAL Diagnostics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial			0.32	0.95	0.41	3.16	2.36

BCAL Diagnostics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

BCAL Diagnostics's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.261	+	(0.897	+	-0.0010000000000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3.16

Total Liabilities	=	Total Assets (A: Jun. 2023 )	-	Total Equity (A: Jun. 2023 )
	=	8.371	-	5.214
	=	3.16

BCAL Diagnostics's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.216	+	(1.139	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2.36

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	8.422	-	6.067
	=	2.36

BCAL Diagnostics Total Liabilities Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

BCAL Diagnostics (ASX:BDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230

Website

https://www.bcaldiagnostics.com

BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.